242 related articles for article (PubMed ID: 32517746)
1. DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningioma.
Vasudevan HN; Castro MRH; Lee JC; Villanueva-Meyer JE; Bush NAO; McDermott MW; Solomon DA; Perry A; Magill ST; Raleigh DR
Acta Neuropathol Commun; 2020 Jun; 8(1):82. PubMed ID: 32517746
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation provides diagnostic value for meningioma recurrence in clinical practice.
Shen E; Leclair NK; Herlth K; Soucy M; Renzette N; Zhuo X; Kelly K; Omerza G; Onyiuke H; McNeill I; Wolansky L; Becker K; Li L; Wu Q; Bulsara KR
Acta Neurochir (Wien); 2023 May; 165(5):1323-1331. PubMed ID: 36920663
[TBL] [Abstract][Full Text] [Related]
4. Total DNA methylation as a biomarker of DNA damage and tumor malignancy in intracranial meningiomas.
Barciszewska AM
BMC Cancer; 2020 Jun; 20(1):509. PubMed ID: 32493231
[TBL] [Abstract][Full Text] [Related]
5. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma.
Paramasivam N; Hübschmann D; Toprak UH; Ishaque N; Neidert M; Schrimpf D; Stichel D; Reuss D; Sievers P; Reinhardt A; Wefers AK; Jones DTW; Gu Z; Werner J; Uhrig S; Wirsching HG; Schick M; Bewerunge-Hudler M; Beck K; Brehmer S; Urbschat S; Seiz-Rosenhagen M; Hänggi D; Herold-Mende C; Ketter R; Eils R; Ram Z; Pfister SM; Wick W; Weller M; Grossmann R; von Deimling A; Schlesner M; Sahm F
Acta Neuropathol; 2019 Aug; 138(2):295-308. PubMed ID: 31069492
[TBL] [Abstract][Full Text] [Related]
6. Mutational signature of extracranial meningioma metastases and their respective primary tumors.
Biczok A; Thorsteinsdottir J; Karschnia P; Ruf VC; Tonn JC; Herms J; Schichor C; Dorostkar MM
Acta Neuropathol Commun; 2023 Jan; 11(1):12. PubMed ID: 36641486
[TBL] [Abstract][Full Text] [Related]
7. Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies.
Bayley JC; Hadley CC; Harmanci AO; Harmanci AS; Klisch TJ; Patel AJ
Sci Adv; 2022 Feb; 8(5):eabm6247. PubMed ID: 35108039
[TBL] [Abstract][Full Text] [Related]
8. HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas.
Di Vinci A; Brigati C; Casciano I; Banelli B; Borzì L; Forlani A; Ravetti GL; Allemanni G; Melloni I; Zona G; Spaziante R; Merlo DF; Romani M
Transl Res; 2012 Nov; 160(5):355-62. PubMed ID: 22735029
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic and Molecular Evaluation of Meningioma.
Davidson C
Neurosurg Clin N Am; 2023 Jul; 34(3):311-318. PubMed ID: 37210122
[TBL] [Abstract][Full Text] [Related]
10. Clonal analysis of a case of multiple meningiomas using multiple molecular genetic approaches: pathology case report.
Zhu JJ; Maruyama T; Jacoby LB; Herman JG; Gusella JF; Black PM; Wu JK
Neurosurgery; 1999 Aug; 45(2):409-16. PubMed ID: 10449091
[TBL] [Abstract][Full Text] [Related]
11. Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome.
Thirimanne HN; Almiron-Bonnin D; Nuechterlein N; Arora S; Jensen M; Parada CA; Qiu C; Szulzewsky F; English CW; Chen WC; Sievers P; Nassiri F; Wang JZ; Klisch TJ; Aldape KD; Patel AJ; Cimino PJ; Zadeh G; Sahm F; Raleigh DR; Shendure J; Ferreira M; Holland EC
Cell Genom; 2024 Jun; 4(6):100566. PubMed ID: 38788713
[TBL] [Abstract][Full Text] [Related]
12. An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures.
Collord G; Tarpey P; Kurbatova N; Martincorena I; Moran S; Castro M; Nagy T; Bignell G; Maura F; Young MD; Berna J; Tubio JMC; McMurran CE; Young AMH; Sanders M; Noorani I; Price SJ; Watts C; Leipnitz E; Kirsch M; Schackert G; Pearson D; Devadass A; Ram Z; Collins VP; Allinson K; Jenkinson MD; Zakaria R; Syed K; Hanemann CO; Dunn J; McDermott MW; Kirollos RW; Vassiliou GS; Esteller M; Behjati S; Brazma A; Santarius T; McDermott U
Sci Rep; 2018 Sep; 8(1):13537. PubMed ID: 30202034
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation.
Vasudevan HN; Braunstein SE; Phillips JJ; Pekmezci M; Tomlin BA; Wu A; Reis GF; Magill ST; Zhang J; Feng FY; Nicholaides T; Chang SM; Sneed PK; McDermott MW; Berger MS; Perry A; Raleigh DR
Cell Rep; 2018 Mar; 22(13):3672-3683. PubMed ID: 29590631
[TBL] [Abstract][Full Text] [Related]
14. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma.
Magill ST; Vasudevan HN; Seo K; Villanueva-Meyer JE; Choudhury A; John Liu S; Pekmezci M; Findakly S; Hilz S; Lastella S; Demaree B; Braunstein SE; Bush NAO; Aghi MK; Theodosopoulos PV; Sneed PK; Abate AR; Berger MS; McDermott MW; Lim DA; Ullian EM; Costello JF; Raleigh DR
Nat Commun; 2020 Sep; 11(1):4803. PubMed ID: 32968068
[TBL] [Abstract][Full Text] [Related]
15. Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features.
Choudhury A; Chen WC; Lucas CG; Bayley JC; Harmanci AS; Maas SLN; Santagata S; Klisch T; Perry A; Bi WL; Sahm F; Patel AJ; Magill ST; Raleigh DR
Neuro Oncol; 2023 Mar; 25(3):520-530. PubMed ID: 36227281
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas.
Kirches E; Sahm F; Korshunov A; Bluecher C; Waldt N; Kropf S; Schrimpf D; Sievers P; Stichel D; Schüller U; Schittenhelm J; Riemenschneider MJ; Karajannis MA; Perry A; Pietsch T; Boekhoff S; Capper D; Beck K; Paramasivam N; Schlesner M; Brastianos PK; Müller HL; Pfister SM; Mawrin C
Acta Neuropathol; 2021 Nov; 142(5):873-886. PubMed ID: 34495383
[TBL] [Abstract][Full Text] [Related]
17. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
Jabini R; Moradi A; Afsharnezhad S; Ayatollahi H; Behravan J; Raziee HR; Mosaffa F
Gene; 2014 Apr; 538(2):348-53. PubMed ID: 24398011
[TBL] [Abstract][Full Text] [Related]
18. Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data.
Shetty A; Wang S; Khan AB; English CW; Nouri SH; Magill ST; Raleigh DR; Klisch TJ; Harmanci AO; Patel AJ; Harmanci AS
J Neurooncol; 2024 Jul; 168(3):515-524. PubMed ID: 38811523
[TBL] [Abstract][Full Text] [Related]
19. RNA-seq transcriptome analysis of formalin fixed, paraffin-embedded canine meningioma.
Grenier JK; Foureman PA; Sloma EA; Miller AD
PLoS One; 2017; 12(10):e0187150. PubMed ID: 29073243
[TBL] [Abstract][Full Text] [Related]
20. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
